RALP as a treatment for prostate cancer in HIV-positive patients
Posted Oct 21 2010 12:00am
A report from the University of California San Diego says that robot-assisted laparoscopic prostatectomy (RALP) appears to be a safe and effective treatment for localized prostate cancer in men who are HIV-positive but are taking highly active antiretroviral therapy (HAART) and have undetectable viral loads (< 50).
Silberstein et al. report that their data suggest HIV-positive patients are at somewhat increased risk for perioperative blood transfusions and ileus (blockage of the lower intestine) compared to HIV-negative males, but that otherwise RALP has similar oncologic outcomes in HIV-positive and HIV-negative men with localized forms of prostate cancer.
A report from the University of California San Diego says that robot-assisted laparoscopic prostatectomy (RALP) appears to be a safe and effective treatment for localized prostate cancer in men who are HIV-positive but are taking highly active antiretroviral therapy (HAART) and have undetectable viral loads (< 50).
Silberstein et al. report that their data suggest HIV-positive patients are at somewhat increased risk for perioperative blood transfusions and ileus (blockage of the lower intestine) compared to HIV-negative males, but that otherwise RALP has similar oncologic outcomes in HIV-positive and HIV-negative men with localized forms of prostate cancer.